Re: Genentch being bought by Roche

[Guest guest]

Sadly, it will not change a thing. Roche is after their cancer research. But,

Xolair represents one of the few drugs that Gennetech owns who's patent was

extended and will not expire before I am too old to care. They see it as a big

money maker for them, even though many doctors will not prescribe it ( too

expensive and too tedious to monitor patients). The payment support should

remain as one, they need to get exposure for the drug and, two, the government

will likely pressure them to make it more accessible to people who benefit from

it.

>

> I saw this in the morning news and thought it interesting since Genentech

produces Xolair. I doubt that much will change as far as Xolair itself is

concerned. What I will be watching is if/how the Xolair payment support

changes.

>

> http://news./s/nm/20090312/ts_nm/us_roche_genentech_11

>

>

> Mike McB

>

[Guest guest]

How about  we wait and see, before  we " jump " to any more  conclusions about

this PENDING purchase of Genentec.  Especially since Xolair is  CO-Owned AND

 Produced by  Genentec AND Novartis Pharmaceuticals Corporation. 

From: billybaroo1958 <cajjz109@...>

Subject: [ ] Re: Genentch being bought by Roche

Date: Thursday, March 12, 2009, 8:57 PM

Sadly, it will not change a thing. Roche is after their cancer

research. But, Xolair represents one of the few drugs that Gennetech owns who's

patent was extended and will not expire before I am too old to care. They see it

as a big money maker for them, even though many doctors will not prescribe it (

too expensive and too tedious to monitor patients). The payment support should

remain as one, they need to get exposure for the drug and, two, the government

will likely pressure them to make it more accessible to people who benefit from

it.

>

> I saw this in the morning news and thought it interesting since Genentech

produces Xolair. I doubt that much will change as far as Xolair itself is

concerned. What I will be watching is if/how the Xolair payment support

changes.

>

> http://news. / s/nm/20090312/ ts_nm/us_ roche_genentech_ 11

>

>

> Mike McB

>

[Guest guest]

I'm hoping that the Access to Care Foundation isn't changed or taken away

completely. That would harm a lot of people. We'll have to wait and see.

>

> >

>

> > I saw this in the morning news and thought it interesting since Genentech

produces Xolair. I doubt that much will change as far as Xolair itself is

concerned. What I will be watching is if/how the Xolair payment support

changes.

>

> >

>

> > http://news. / s/nm/20090312/ ts_nm/us_ roche_genentech_ 11

>

> >

>

> >

>

> > Mike McB

>

> >

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>